- Collins B, Kypridemos C, Cookson R, Parvulescu P, McHale P, Guzman-Castillo M, et al. Universal or targeted cardiovascular screening? Modelling study using a sector-specific distributional cost effectiveness analysis. Prev Med. 2019:105879.
- Connor D, Coppell K, Gray A, Sullivan T. A cost-effectiveness analysis of the Prediabetes Intervention Package (PIP) in primary care: a New Zealand pilot programme. N Z Med J. 2019;132(1504):24-34.
- Duhig KE, Seed PT, Myers JE, Bahl R, Bambridge G, Barnfield S, et al. Placental growth factor testing for suspected pre-eclampsia: a cost-effectiveness analysis. Bjog. 2019;126(11):1390-8.
- Werbrouck A, Schmidt M, Putman K, Annemans L, Benhalima K, Simoens S, et al. Cost-utility analysis of lifestyle interventions to prevent type 2 diabetes in women with prior gestational diabetes. Eur J Public Health. 2019.
- Zeevat F, van der Schans J, Boersma WG, Boersma C, Postma MJ. Cost-effectiveness analysis on elderly pneumococcal vaccination in the Netherlands: Challenging the Dutch Health Council's advice. Vaccine. 2019;37(43):6282-4.
HEDS is part of the School of Health and Related Research (ScHARR) at the University of Sheffield. We undertake research, teaching, training and consultancy on all aspects of health related decision science, with a particular emphasis on health economics, HTA and evidence synthesis.
Wednesday, 13 November 2019
October's CEAs.....
We’ve completed our quick search for CEA’s published last month. In the right-hand column of this blog is a CEA Archive of all records. Below are those in our areas of interest.